Stefania Mazzoleni

Stefania Mazzoleni currently serves as Scientific Director & Communication Officer at Genenta where she manages and oversees the scientific development of parallel immuno-gene therapy studies in oncology indications and provides scientific support for Investor interactions, by combining deep pre-clinical and scientific area-specific knowledge to clinical research experience. Stefania has more than 15 years’ experience in life science R&D, oncology and project management, including more than 4 years in drug development and cell & gene therapy from various academic institutions and pharmas. Stefania received a MsC in Medical Biotechnology, holds her Ph.D. in Molecular and Cellular Biology from San Raffaele Vita-Salute University, has a Second level vocational Master’s in Pharmacy and Pharmaceutical Oncology and is a member of the European Academy of Tumor Immunology (EATI).